Participate Today
Save Lives Tomorrow!

Featured Study

NASH Trial

FOMAT is enrolling participants for a NASH Clinical Trial.

Non-alcoholic steatohepatitis (NASH) is a silent disease that often stays asymptomatic until advanced stages. It involves excess liver fat, leading to inflammation and damage over time. In early phases, it goes unnoticed, but as NASH advances, it can become cirrhosis, severely impairing liver function and risking complications. Early detection and action are vital to prevent NASH progression and protect liver health.

Which Clinical Trial Do You Want To Participate In?

Active Studies

Filter Trials By Status

Filter Trials By Location

Filter Trials By Age

Filter Trials by Condition

  • Ventura

    Asthma Study

    Asthma is a chronic condition that inflames and narrows the airways, causing difficulty breathing. Symptoms include coughing, wheezing, shortness of breath, and chest tightness.

    Criteria & Qualifications: • Must be 12 years or older.
    • Must have an Asthma diagnosis.
    • Must be able to provide medical records.

    Compensation: Up to $2,000

    Read more
  • Camarillo, Oxnard

    NASH Study

    Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH.

    Criteria & Qualifications:  • Is at least 18 years of age or older.
    • Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
    • Must be weight stable for 6 months.

    Compensation: Up to $3,000.

    Read more

Participate Today
Save Lives Tomorrow!

Get Paid to be part of Advancing Research! ​


    What Are Clinical Trials And Are They Safe?

    KVs_Web Banner.ai (6)